澳门新葡亰网站所有平台_澳门新葡亰9798登录入口

National Key Clinical Specialties

Oncology Department

Our hospital was founded in 1955. After more than 60 years of construction and development, it has gradually formed a three-level first-class hospital characterized by the diagnosis and treatment of tumors. At present, there are 53 clinical and medical technology departments in tumor related professional departments, which are engaged in a series of clinical medical services from tumor screening, diagnosis to standardized treatment.

The oncology related majors include thoracic surgery, breast surgery, gastrointestinal surgery, anorectal surgery, hepatobiliary surgery, head and neck surgery (otolaryngology), orthopedics, Urology, Stomatology, neurosurgery, ophthalmology, gynecology, radiotherapy, oncology, pediatric oncology, oncology, biotherapy, pain rehabilitation, etc., covering 59 nursing units, 1994 beds, with There are radiology and interventional department, CT and MRI diagnosis and treatment department, endoscopy diagnosis and treatment department, nuclear medicine department, ultrasound function department, cancer testing center, pathology department and molecular pathology diagnosis room and other medical technology departments.

Every year, there are about 400000 cancer outpatients, 21000 operations, 4600 radiotherapy and 20000 chemotherapy. Esophageal cancer, lung cancer, thyroid cancer, breast cancer, gastric cancer, colorectal cancer, hepatobiliopancreatic tumor, bone tumor, cervical and ovarian cancer, hematological disease lymphoma, etc. are the strong projects of cancer specialty in our hospital.

In terms of diagnosis and treatment of esophageal cancer, accurate staging was carried out according to imaging, endoscopy, pathology and other technologies to determine the procedures of comprehensive treatment such as surgery, radiotherapy and chemotherapy, targeted treatment, etc., and accurate target area mapping of radiotherapy after endoscopic treatment, surgical treatment and three-dimensional reconstruction of esophageal cancer was carried out. More than 2000 cases of standardized comprehensive treatment were received annually. The clinical staging standard for non-surgical treatment of esophageal cancer has been formulated It is popularized all over the country. CT low dose rate thin-layer scanning has been used in 14010 cases of early lung cancer screening, and the detection rate of cancer is 0.7%. The accuracy of early diagnosis and clinical stage of lung cancer was improved by carrying out lung cancer operation, radiotherapy and chemotherapy, molecular targeted treatment, and endoscopic guided transbronchial needle aspiration biopsy. Thoracoscopic resection of lung segment or subpulmonary segment can avoid postoperative pulmonary dysfunction. The diagnosis and treatment of mediastinal masses under mediastinoscopy were carried out.

Laparoscopic and open standardized radical operation and postoperative adjuvant chemotherapy for digestive tract cancer, especially for advanced esophageal gastric junction cancer and colorectal cancer, improved the radical resection rate. Three step laparoscopic left lateral lobectomy and pancreatoduodenectomy were carried out for the treatment of early gastric cancer, colorectal cancer under endoscopy, jejunal interposition after resection of esophageal gastric junction cancer, anus preserving operation for low rectal cancer, TME and CME for colorectal cancer, and liver cancer and gallbladder cancer.

We have carried out endoscopic radical surgery for gynecological tumors, especially for cervical cancer with pelvic autonomic nerve reserved.

The intraperitoneal malignant tumors were treated with chemotherapy and systemic therapy. Radical operation was performed on renal cancer, ureteral cancer and bladder cancer, and functional treatment was emphasized.

To establish a screening model for high-risk population of breast cancer, to carry out the general survey of breast cancer; according to different clinical stages, to carry out radical surgery, preoperative neoadjuvant chemotherapy, postoperative adjuvant radiotherapy and chemotherapy, endocrine and targeted treatment, especially breast reconstruction, modified radical mastectomy of latissimus dorsi reduction, sentinel lymph node biopsy of early breast adenocarcinoma, minimally invasive treatment of mammoscopy, and comprehensive treatment of triple negative breast cancer.

To carry out B-ultrasonic screening and functional treatment of thyroid cancer, especially the application of intraoperative laryngeal nerve anatomy monitoring, nano carbon negative development, micro amplification and other technologies.

Based on the molecular biological classification of lymphoma, individualized chemotherapy and molecular targeted therapy were carried out.

The metastasis of bone and soft tissue tumor was treated by operation, radiotherapy and chemotherapy, radionuclide and so on.

The mechanism of invasion, metastasis and recurrence of malignant tumors, the detection of related molecular biological indicators, the clinical basis of traditional Chinese medicine and biological immunotherapy, and the research of translational medicine were carried out to explore new ways and methods of diagnosis and treatment of malignant tumors.